Myosin Activation as a Novel Therapeutic Strategy for Polycystic Kidney Disease
肌球蛋白激活作为多囊肾病的新型治疗策略
基本信息
- 批准号:10313782
- 负责人:
- 金额:$ 2.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2022-03-27
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalActomyosinAdhesionsAffectAgonistArchitectureAutosomal Dominant Polycystic KidneyBiochemicalBiological AssayBiological ModelsBiological ProductsBiologyBlood Urea NitrogenBlood specimenBody WeightCalmodulinCell modelCellsClinicalContractsCreatinineCystDataDiseaseDoseDrug ScreeningEffectivenessEnsureEpithelialExperimental ModelsFibrosisFilamentFluorescenceFunctional disorderG-Protein-Coupled ReceptorsGeneticGoalsGrowthHarvestHeartHeart AbnormalitiesHemodialysisHepatic CystHumanImageImage AnalysisIn VitroIndividualKidneyKidney FailureKidney TransplantationLigandsLightLinkLiquid substanceLiteratureLiverMeasuresModelingModificationMolecularMotorMovementMusMutationMyosin ATPaseMyosin Phosphatase PathwayNonmuscle Myosin Type IIAOrganOrgan failureOrganismOrganoidsPKD2 proteinPathway interactionsPeptidesPharmaceutical PreparationsPhenocopyPhosphorylationPolycystic Kidney DiseasesPre-Clinical ModelPreclinical Drug DevelopmentPreventionProceduresProductionProtein FamilyProteinsRenal functionRenal tubule structureReporterSignal TransductionSlideStimulusStructureSystemTestingTherapeuticTissuesTranslatingTubular formationWorkbaseblebbistatincurative treatmentsdisease-in-a-dishdrug candidatedrug developmentdrug discoverydruggable targetefficacy evaluationefficacy testingexperimental studyin vivoinhibitor/antagonistinnovationinsightkidney cellloss of functionmembermouse modelmutantnon-muscle myosinnovelnovel therapeutic interventionpolycystic kidney disease 1 proteinpre-clinicalpreventprotein aminoacid sequencereceptorresponsesmall moleculestem cellstherapeutically effectivetreatment strategy
项目摘要
ABSTRACT
Autosomal dominant polycystic kidney disease (ADPKD) affects 1 in every 400-1000 people worldwide,
causing progressive fluid-filled cyst production in the kidneys, liver, and other organs, resulting in organ failure.
PKD is caused by mutations in the polycystin proteins polycystin-1 (PC1) or polycystin-2 (PC2). A clear
understanding of how polycystin dysfunction leads to cysts mechanistically is still elusive, due, in part, to the
lack of cyst producing model systems that accurately phenocopy the disease. Stem cell derived human kidney
organoids model PKD cystogenesis in a specific way and have potential to accelerate drug discovery and
development for PKD.
Using these PKD organoids, a drug screen was performed identifying blebbistatin, a myosin inhibitor, as a
potent cyst agonist. Subsequently, I discovered that EMD, a myosin activator, showed pre-clinical promise in
treating PKD cystogenesis in PKD organoids at both early and late stages of disease. Based upon preliminary
data and clues from the literature, I hypothesize that PC1 and PC2 positively regulate non-muscle myosin
contractility within the tubular epithelium to prevent cystogenesis.
Utilizing the unique kidney organoid in vitro system, I propose to analyze myosin modulator compounds and
non-muscle myosin dynamics in organoids to pinpoint the myosin domain that governs cyst expansion to
inform pre-clinical drug development. Second, I aim to optimize in vivo delivery and treatment strategies of
EMD in a mouse model of PKD. Finally, I will utilize the insight that PC1 structurally resembles an atypical
adhesion G-protein coupled receptor to analyze whether biochemically activating PC1 can stimulate organoid
contraction to link polycystin function to myosin control. Together, these experiments will establish myosin
activation as a therapeutic strategy to treat PKD and determine mechanisms of PC1 as a regulator of myosin
contractility. The goal of this work is to expedite drug discovery for PKD by utilizing model systems that best
represent the disease, and mechanistic studies that inform polycystin function in cystogenesis.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Louisa M Helms其他文献
Louisa M Helms的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
- 批准号:82360313
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Nuclear force feedback as rheostat for actomyosin tension control
核力反馈作为肌动球蛋白张力控制的变阻器
- 批准号:
MR/Y001125/1 - 财政年份:2024
- 资助金额:
$ 2.96万 - 项目类别:
Research Grant
CAREER: Cytokinesis without an actomyosin ring and its coordination with organelle division
职业:没有肌动球蛋白环的细胞分裂及其与细胞器分裂的协调
- 批准号:
2337141 - 财政年份:2024
- 资助金额:
$ 2.96万 - 项目类别:
Continuing Grant
CAREER: Computational and Theoretical Investigation of Actomyosin Contraction Systems
职业:肌动球蛋白收缩系统的计算和理论研究
- 批准号:
2340865 - 财政年份:2024
- 资助金额:
$ 2.96万 - 项目类别:
Continuing Grant
Elucidation of the mechanism by which actomyosin emerges cell chirality
阐明肌动球蛋白出现细胞手性的机制
- 批准号:
23K14186 - 财政年份:2023
- 资助金额:
$ 2.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Deciphering actomyosin contractility regulation during incomplete germ cell division
破译不完全生殖细胞分裂过程中肌动球蛋白收缩性的调节
- 批准号:
573067-2022 - 财政年份:2022
- 资助金额:
$ 2.96万 - 项目类别:
University Undergraduate Student Research Awards
CAREER: Actuating robots with actomyosin active gels
职业:用肌动球蛋白活性凝胶驱动机器人
- 批准号:
2144380 - 财政年份:2022
- 资助金额:
$ 2.96万 - 项目类别:
Continuing Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
- 批准号:
2201236 - 财政年份:2022
- 资助金额:
$ 2.96万 - 项目类别:
Standard Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
- 批准号:
2201235 - 财政年份:2022
- 资助金额:
$ 2.96万 - 项目类别:
Standard Grant
Coordination of actomyosin and anillo-septin sub-networks of the contractile ring during cytokinesis
胞质分裂过程中收缩环肌动球蛋白和 anillo-septin 子网络的协调
- 批准号:
463633 - 财政年份:2022
- 资助金额:
$ 2.96万 - 项目类别:
Operating Grants
The integrin-dependent B cell actomyosin network drives immune synapse formation and B cell functions
整合素依赖性 B 细胞肌动球蛋白网络驱动免疫突触形成和 B 细胞功能
- 批准号:
546047-2020 - 财政年份:2021
- 资助金额:
$ 2.96万 - 项目类别:
Postdoctoral Fellowships